Graft Versus Host Disease (GVHD): Epidemiology Forecasting Intelligence

Date: March 1, 2019
Pages: 50
Price:
US$ 2,500.00
License [?]:
Publisher: CmaxInsight Market Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G0CF117A372EN
Leaflet:

Download PDF Leaflet

Graft Versus Host Disease (GVHD): Epidemiology Forecasting Intelligence
CmaxInsight’s “Graft Versus Host Disease (GVHD)-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Graft Versus Host Disease (GVHD) epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.

Our epidemiology services include:
  • Incidence and prevalence
  • Diagnosis rate, treatment rate and mortality patterns
  • Epidemiology-based forecasting and disease trends
  • Size of different patient segments in a disease area
  • Population based: disease occurrence, co-morbidities and treatment patterns
  • Geographic - Regional - Ethnic differences
Along with the epidemiological data, the report also includes:
  • Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
  • Patient treatment journey
  • Treatment algorithm and guidelines
  • Assesses the disease risk and burden
  • Highlights the unmet needs
  • Market driver and barrier
  • Growth opportunities and market trend analysis
Methodology
  • This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
  • To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
  • All of the sources used to generate the data and analysis have been identified in the report.
Note: Systematic review of the epidemiological literature is also provided for full transparency into research and methods. This report can be delivered to the clients within 4-5 business days.
1. REPORT INTRODUCTION

2. GRAFT VERSUS HOST DISEASE (GVHD) EPIDEMIOLOGY OVERVIEW AT A GLANCE

3. MARKET SHARE DISTRIBUTION OF GRAFT VERSUS HOST DISEASE (GVHD)

4. DISEASE BACKGROUND AND OVERVIEW: GRAFT VERSUS HOST DISEASE (GVHD)

4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
  4.6.1. Diagnostic Practices
  4.6.2. Diagnostic Criteria
  4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
  4.7.1. Current Treatment Practices
  4.7.2. Treatment Algorithm
  4.7.3. Treatment Recommendations

5. GRAFT VERSUS HOST DISEASE (GVHD) EPIDEMIOLOGY

5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology

6. EPIDEMIOLOGY OF GRAFT VERSUS HOST DISEASE (GVHD) BY COUNTRIES

7. UNITED STATES

7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
7.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
7.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
7.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
7.6. Treated Cases of Graft Versus Host Disease (GVHD)

8. EU5

8.1. Germany
  8.1.1. Assumptions and Rationale
  8.1.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
  8.1.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
  8.1.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
  8.1.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
  8.1.6. Treated Cases of Graft Versus Host Disease (GVHD)
8.2. France
  8.2.1. Assumptions and Rationale
  8.2.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
  8.2.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
  8.2.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
  8.2.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
  8.2.6. Treated Cases of Graft Versus Host Disease (GVHD)
8.3. United Kingdom
  8.3.1. Assumptions and Rationale
  8.3.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
  8.3.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
  8.3.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
  8.3.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
  8.3.6. Treated Cases of Graft Versus Host Disease (GVHD)
8.4. Spain
  8.4.1. Assumptions and Rationale
  8.4.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
  8.4.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
  8.4.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
  8.4.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
  8.4.6. Treated Cases of Graft Versus Host Disease (GVHD)
8.5. Italy
  8.5.1. Assumptions and Rationale
  8.5.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
  8.5.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
  8.5.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
  8.5.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
  8.5.6. Treated Cases of Graft Versus Host Disease (GVHD)

9. JAPAN

9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Graft Versus Host Disease (GVHD)
9.3. Sub-Type Specific cases of Graft Versus Host Disease (GVHD)*
9.4. Sex- Specific Cases of Graft Versus Host Disease (GVHD)*
9.5. Diagnosed Cases of Graft Versus Host Disease (GVHD)
9.6. Treated Cases of Graft Versus Host Disease (GVHD)

10. UNMET NEEDS

Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.

LIST OF TABLES

Table 1: Total Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in United States
Table 4: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in United States*
Table 5: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in United States*
Table 6: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in United States
Table 7: Treated Cases of the Graft Versus Host Disease (GVHD) in United States
Table 8: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Germany
Table 9: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Germany*
Table 10: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Germany*
Table 11: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Germany
Table 12: Treated Cases of the Graft Versus Host Disease (GVHD) in Germany
Table 13: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in France
Table 14: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in France*
Table 15: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in France*
Table 16: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in France
Table 17: Treated Cases of the Graft Versus Host Disease (GVHD) in France
Table 18: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Italy
Table 19: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Italy*
Table 20: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Italy*
Table 21: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Italy
Table 22: Treated Cases of the Graft Versus Host Disease (GVHD) in Italy
Table 23: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Spain
Table 24: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Spain*
Table 25: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Spain*
Table 26: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Spain
Table 27: Treated Cases of the Graft Versus Host Disease (GVHD) in Spain
Table 28: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in UK
Table 29: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in UK*
Table 30: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in UK*
Table 31: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in UK
Table 32: Treated Cases of the Graft Versus Host Disease (GVHD) in UK
Table 33: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Japan
Table 34: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Japan*
Table 35: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Japan*
Table 36: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Japan
Table 37: Treated Cases of the Graft Versus Host Disease (GVHD) in Japan

*Indication Specific

LIST OF FIGURES

Figure 1: Total Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in United States
Figure 4: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in United States*
Figure 5: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in United States*
Figure 6: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in United States
Figure 7: Treated Cases of the Graft Versus Host Disease (GVHD) in United States
Figure 8: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Germany
Figure 9: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Germany*
Figure 10: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Germany*
Figure 11: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Germany
Figure 12: Treated Cases of the Graft Versus Host Disease (GVHD) in Germany
Figure 13: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in France
Figure 14: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in France*
Figure 15: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in France*
Figure 16: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in France
Figure 17: Treated Cases of the Graft Versus Host Disease (GVHD) in United France
Figure 18: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Italy
Figure 19: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Italy*
Figure 20: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Italy*
Figure 21: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Italy
Figure 22: Treated Cases of the Graft Versus Host Disease (GVHD) in Italy
Figure 23: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Spain
Figure 24: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Spain*
Figure 25: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Spain*
Figure 26: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Spain
Figure 27: Treated Cases of the Graft Versus Host Disease (GVHD) in Spain
Figure 28: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in UK
Figure 29: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in UK*
Figure 30: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in UK*
Figure 31: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in UK
Figure 32: Treated Cases of the Graft Versus Host Disease (GVHD) in UK
Figure 33: Prevalent/Incident Cases of the Graft Versus Host Disease (GVHD) in Japan
Figure 34: Sub-Type Specific Cases of the Graft Versus Host Disease (GVHD) in Japan*
Figure 35: Sex- Specific Cases of the Graft Versus Host Disease (GVHD) in Japan*
Figure 36: Diagnosed Cases of the Graft Versus Host Disease (GVHD) in Japan
Figure 37: Treated Cases of the Graft Versus Host Disease (GVHD) in Japan

*Indication Specific
Skip to top


Ask Your Question

Graft Versus Host Disease (GVHD): Epidemiology Forecasting Intelligence
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: